Oyster Point Pharma Inks Deal with Ji Xing for Dry Eye Disease Therapies

Oyster Point Pharma, based in Princeton, N.J., inked a license and collaboration deal with Shanghai, China-based Ji Xing Pharmaceuticals to develop and market OC-01 (varenicline) and OC-02 (simpinicline) nasal sprays for dry eye disease in Great China.